It looks like you're using an Ad Blocker.
Please white-list or disable AboveTopSecret.com in your ad-blocking tool.
Some features of ATS will be disabled while you continue to use an ad-blocker.
Scientists have discovered a new way to attack dangerous pathogens, marking a hopeful next step in the ever-escalating battle between man and microbe.
"This offers a whole new way to go on the offensive against some of the world's most dangerous bugs," said the leader of the group, Paul Dunman, Ph.D., associate professor of Microbiology and Immunology at the University of Rochester Medical Center and formerly of the University of Nebraska. "We're hoping our research opens the door to an entirely new class of antibiotics."
Originally posted by Amaterasu
Oh, THIS will be quashed! Cured people are not buyers of pharmaceuticals. Cured people don't go to doctors.
The fact that colloidal silver is nigh impossible to buy ready-made (and that they seriously suggested making turmeric - shown to reduce tumors and used as a spice throughout our present history - ILLEGAL!) is a clue that cures are highly discouraged.
Originally posted by Miraj
reply to post by Amaterasu
I am sure in all your wisdom.
You may have considered that.
Dead people are bad for life insurers.
A major milestone in microfluidics could soon lead to stand-alone, self-powered chips that can diagnose diseases within minutes. The device, developed by an international team of researchers from the University of California, Berkeley, Dublin City University in Ireland and Universidad de Valparaíso Chile, is able to process whole blood samples without the use of external tubing and extra components.
I'm sure in all your wisdom you have considered that dead people don't matter - there are PLENTY more where they came from, and that lingering illness (whenever death eventually occurs) reaps HUGE profits, mostly for the pharmaceutical companies, but also for both doctors and hospitals. The insurance companies would probably LOVE for cures to be offered but they are fully trumped by the enormously powerful pharmaceutical companies (and premiums are still collected from the living...)
The US House of Representatives last month approved a $1.6bn cut to the National Institutes of Health’s current budget, a 5.2 per cent cut from 2010 and one that brings its funding back to 2008 levels.
In February, Pfizer announced plans to cut $3bn from its $9bn research budget, while last year GlaxoSmithKline reduced the proportion of sales it invests in R&D for prescription medicines.